About Kimer Med

Biomedical scientist using a pipette and microscope

Our dedicated team of scientists is committed to an audacious vision: an end to viral disease.

Rick Kiessig - Kimer Med Co-Founder & CEO

“We have an opportunity to relieve the tremendous pain and suffering caused by viral diseases. I can't imagine anything more important, exciting or impactful.”

About Kimer Med

Kimer Med was founded in 2020 to pursue a vision to end viral disease with a family of safe and effective broad-spectrum antivirals. We are a small, but growing, company with a team of seven currently.

Our headquarters are in Nelson, New Zealand. Although not a well-known biotech or life sciences hub, Nelson is home to more scientists (on a per capita basis) than any other city in New Zealand, thanks largely to the establishment of the Cawthron Institute in 1919. The Nelson region is also the birthplace of Lord Ernest Rutherford, who is considered "the father of nuclear physics".

The Kimer Med team

  • Rick Kiessig

    CO-FOUNDER
    CEO & CSO

  • Phil Oliver

    CO-FOUNDER
    CTO & CHIEF BIOINFORMATICIAN

  • Dr Sophie Walker

    LEAD SCIENTIST

  • Bridget Scaife

    EXECUTIVE ASSISTANT

  • Andy Clover

    COMMS & RELATIONSHIPS LEAD

  • Dr Geena McKenzie-Goldsmith

    BIOMEDICAL SCIENTIST

  • Tanja Wiles

    LABORATORY MANAGER

Advisory Board

Dr Mauro Teixeira
ADVISOR

Dr Mauro Teixeira is recognised as a world leader in Dengue research. He obtained his PhD at the University of London and has worked in Brazil since 1997.

Mauro is a Professor of Immunology at the Department of Biochemistry and Immunology and Head of the Center for Advanced and Innovative Therapies at Universidade Federal de Minas Gerais (UFMG), Brazil. He is a full member of the Brazilian Academy of Science, of the National Order of Scientific Merit and of The World Academy of Sciences (TWAS).

Mauro is past-president of the Brazilian Society of Pharmacology (SBFTE) and of the Brazilian Society of Inflammation (SBIN). Currently he is vice-president of the International Association of Inflammation Societies (IAIS) and chair of the Immunotherapy Committee of the International Union of Immunological Societies (IUIS). He is member of the Medicines advisory board for ANVISA.

Mauro also coordinates the National Institute of Science and Technology in Dengue and host-microbial interactions (INCT Dengue).

We are currently recruiting for our Advisory Board.

Careers at Kimer Med

There are no current vacancies. Please subscribe to our newsletter and follow us on social media to be notified of upcoming roles.

OUR MISSION

We’re developing a family of broad-spectrum antiviral drugs.

Assisted by our advisors, partners and expert consultants, we have a comprehensive plan to achieve our goals.